COVID 19: Clinical Trials

4 trials for COVID 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow COVID 19: new trials by email Literature Review of COVID 19 trials Research Report on COVID 19

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION
MR or M-M-R II ® vaccine, Placebo - COVID 19
Phase 3CompletedWashington University School of Medicine34112020-09-042024-03-26
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia
Almitrine, Placebo - Covid 19, Hypoxemic Respiratory Failure
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1812020-09-032022-05-03
Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
Hydroxychloroquine, Oseltamivir, Azithromycin - COVID 19
Phase 3CompletedShehnoor Azhar5502020-04-222022-02-10
Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19
Collagen-polyvinylpyrrolidone, Pirfenidone 1200 mg - COVID 19
Phase 2 / Phase 3CompletedMaterno-Perinatal Hospital of the State of Mexico362020-02-012024-09-05

Narrower conditions

COVID-19 (4)  ·  Respiratory Insufficiency (1)

Broader conditions

Coronaviridae Infections (4)  ·  Coronavirus Infections (4)  ·  Infections (4)  ·  Lung Diseases (4)  ·  Nidovirales Infections (4)  ·  Pneumonia (4)  ·  Pneumonia, Viral (4)  ·  RNA Virus Infections (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Virus Diseases (4)  ·  Respiration Disorders (1)

Interventions

Almitrine (1)  ·  Azithromycin (1)  ·  Hydroxychloroquine (1)  ·  Oseltamivir (1)  ·  collagen-PVP (1)  ·  pirfenidone (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Materno-Perinatal Hospital of the State of Mexico (1)  ·  Shehnoor Azhar (1)  ·  Washington University School of Medicine (1)

Countries

France (1)  ·  Ghana (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  South Africa (1)  ·  United Kingdom (1)  ·  United States (1)  ·  Zambia (1)

Top investigators

Helen Rees, MD (1)  ·  Javed Akram, FRCP (1)  ·  Michael S. Avidan, MBBCh (1)  ·  Ramani Moonesinghe, MD (1)

Results publications

PMID 32771032, PMID 34473343, PMID 35713300, PMID 35799756, PMID 36157895, PMID 37153751, PMID 38827854, PMID 41035643